Le Lézard
Classified in: Science and technology, Business
Subjects: ERN, CCA

Infosys to Announce First Quarter Results on July 15, 2020


BENGALURU, India, July 9, 2020 /CNW/ -- Infosys (NSE, BSE, NYSE: INFY), a global leader in next-generation digital services and consulting, will announce results for the first quarter ended June 30, 2020 on Wednesday, July 15, 2020 around 3:45 p.m. Indian Standard Time (IST) (6:15 a.m. US ET; 3:15 a.m. PST; 11:15 a.m. London time; 6:15 p.m. Singapore/Hong Kong time). The results will also be available on www.infosys.com.

Infosys_Logo

Common press conference (Hosted virtually)

(4:30 p.m. IST; 7:00 a.m. ET)

Following the release, the leadership team will be part of a common press conference at 4:30 p.m. IST. The participating executives will address questions from the media during this interaction which will be streamed live on the Investor Relations section of Infosys website, following which it will be archived at www.infosys.com. The archive will be available after 7:00 p.m. IST on July 15, 2020 (after 9:30 a.m. US ET on July 15, 2020). In addition, a transcript of the conference will be available at www.infosys.com.

Earnings call

(6:00 p.m. IST; 8:30 a.m. ET)

The company will conduct a single 60-minute conference call at 6:00 p.m. IST (8:30 a.m. US ET; 5:30 a.m. PST; 1:30 p.m. London time; 8:30 p.m. Singapore/Hong Kong time) on July 15, 2020 (open to investors/analysts in all regions), where the senior management will discuss company's performance and answer questions from participants. To participate in the conference call, please dial the numbers provided below 10 ? 15 minutes before the scheduled start time of the call. During this time, the operator will provide instructions on how to ask questions. Alternatively, you can also pre-register yourself using the DiamondPasstm link provided below which will enable you to connect to the conference call without having to wait for an operator. As participation in the call is limited, early registration is encouraged.

This event will be webcast live on the Investor Relations section of Infosys website, following which it will be archived at www.infosys.com. The archive will be available after 8:30 p.m. IST on July 15, 2020 (after 11:00 a.m. US ET on July 15, 2020). In addition, a transcript of the conference call will be available at www.infosys.com.

Summary of events

Event

Date and Time

Web-site/ Region

Telephone No.

Earnings release over the wire services

3:45 p.m. IST

 

6:15 a.m. ET

 

July 15, 2020

www.infosys.com


Common press conference (Hosted virtually)

4:30 p.m. IST

 

7:00 a.m. ET

 

July 15, 2020

www.infosys.com

Dial-in details to be shared with participants

Event

Date and Time

Web-site/ Region

Telephone No.

Earnings conference call

(open for questions from investors / analysts in all regions)

6:00 p.m. IST

 

8:30 a.m. ET

 

July 15, 2020

 

Questions during the call can be addressed to [email protected]

 

DiamondPasstm registration link

 

https://services.choruscall.in/DiamondPassRegistration/register?confirmationNumber=121172&linkSecurityString=4d9cb008

 

India

Toll, Mumbai:

+91 22 6280 1168

+91 22 7115 8069

 

Toll, Bangalore:

+91 7045671221

US

Toll-free: 

1 866 746 2133

 

Toll Number:

+1 323 386 8721

Singapore

Toll-free: 
800 101 2045

 

Toll-number: 
+65 3157 5746

Hong Kong

Toll-free:
800 964 448 

 

Toll Number:

+852 3018 6877

Japan

Toll Free:

0053 116 1110

 

Toll Number:

+81 3 4589 9421

UK

Toll Free:

0 808 101 1573

 

Toll Number:

+44 203 478 5524

Germany

Toll-free: 
00 8001 424 3444

Canada

Toll- free:

011 8001 424 3444

France

Toll-free: 
0 800 914 745

Replay of conference call

Till July 22, 2020

www.infosys.com

Toll-free, USA:

1 833 289 8317

 

International toll:

+ 1 347 974 7488

 

Toll, Mumbai/India:

+91 22 7194 5757

 

Playback code: 4637#

About Infosys Ltd.

Infosys is a global leader in next-generation digital services and consulting. We enable clients in 46 countries to navigate their digital transformation. With nearly four decades of experience in managing the systems and workings of global enterprises, we expertly steer our clients through their digital journey. We do it by enabling the enterprise with an AI-powered core that helps prioritize the execution of change. We also empower the business with agile digital at scale to deliver unprecedented levels of performance and customer delight. Our always-on learning agenda drives their continuous improvement through building and transferring digital skills, expertise, and ideas from our innovation ecosystem.

Visit www.infosys.com to see how Infosys (NYSE: INFY) can help your enterprise navigate your next.

 

SOURCE Infosys


These press releases may also interest you

at 08:25
Aurion Biotech, whose mission is to restore vision to millions of patients with life-changing regenerative therapies, today announced that it has dosed the first Canadian subject in its Phase 1 / 2 clinical trial (ABA-1, CLARA) of AURN001, a cell...

at 08:20
The "Highly Potent API Market - A Global and Regional Analysis: Focus on Type, Type of Synthesis, Therapeutic Area, Type of Manufacturing, End User, and Country - Analysis and Forecast, 2023-2033" report has been added to ResearchAndMarkets.com's...

at 08:15
Keysight Technologies , today announced its intention to acquire the entire issued and to be issued share capital of Spirent Communications PLC (London Stock Exchange Symbol: SPT) ("Spirent") for a cash consideration of 199 pence per Spirent share...

at 08:15
VarmX, a biotech company focusing on the development of innovative approaches for the reversal of anticoagulation, today announces that it will be attending the LSX World Congress (29-30 April) and presenting at Bio?quity Europe (12-14 May). The...

at 08:15
Azura Ophthalmics Ltd., a clinical-stage biopharmaceutical company developing a potential new therapeutic class of Ophthalmic Keratolytics for ocular surface diseases, today announced multiple presentations highlighting positive efficacy and safety...

at 08:15
Nuvation Bio Inc. , a biopharmaceutical company tackling some of the greatest unmet needs in oncology by developing differentiated and novel therapeutic candidates, today announced the appointment of Colleen Sjogren as Chief Commercial Officer. Ms....



News published on and distributed by: